Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
measles, mumps, rubella and varicella vaccine (live) (Zydus Lifesciences Limited)
- Development stage
- Unknown
- Lead developer
- Zydus Lifesciences
- Modality
- Live Attenuated Vaccines → Live Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics
- Administration
- Injection
01
Overview
Zydus Lifesciences is developing a live attenuated combination vaccine (MMRV) for the prevention of measles, mumps, rubella, and varicella (chickenpox). This freeze-dried formulation is designed to provide immunity against all four viral pathogens in a single injection. The vaccine works by introducing attenuated strains of the Measles morbillivirus, Mumps orthorubulavirus, Rubella virus, and Varicella-zoster virus, which stimulate the immune system to produce protective antibodies. As of 2025, the development was in Phase I following regulatory guidance from the CDSCO to establish safety in healthy adults before proceeding to pediatric trials.
- Other names
- Zydus MMRV vaccine
Beyond the preview
Go deeper on measles, mumps, rubella and varicella vaccine (live) (Zydus Lifesciences Limited).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on measles, mumps, rubella and varicella vaccine (live) (Zydus Lifesciences Limited).